Cyclophosphamide trials for Lupus Nephritis

All Cyclophosphamide trials · All Lupus Nephritis trials

Phase breakdown

Recruiting trials studying Cyclophosphamide for Lupus Nephritis

• A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease
  NCT06308978 · Phase: Phase 1 · Ages: 12 Years to 70 Years · Sex: All (male and female) · 21 locations
• Minimizing Glucocorticoid Administration in Patients With Proliferative Lupus Nephritis
  NCT05207358 · Phase: Phase 4 · Ages: 18 Years to 80 Years · Sex: All (male and female) · 1 location
• Phase I/II Study of AD-PluReceptor Plus Tafasitamab-cxix and Lymphodepleting Chemotherapy in Patients With Autoimmune Disorders
  NCT06434363 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• SELECT-SLE: Biomarker-Guided CAR-T Target Selection for Refractory Lupus
  NCT07523542 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 70 Years · Sex: All (male and female) · 1 location
• US Zamto-cel Autoimmune Diseases
  NCT06708845 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 1 location

Common questions

How many trials study Cyclophosphamide for Lupus Nephritis?

5 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.